G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/74 (2006.01) G01N 33/53 (2006.01)
Patent
CA 2233724
This invention is directed to a method of diagnosing cardiac transplant rejection within a patient comprising, obtaining a sample of a biological fluid from said patient, and determining the level of a brain natriuretic peptide (BNP) or a fragment thereof, within said sample of body fluid. The step of determining the concentration of BNP involves an assay comprising at least one antibody exhibiting affinity for said BNP or a fragment thereof, and the biological fluid comprises plasma, urine or cerebrospinal fluid. Furthermore, the antibody used within the method may comprises a polyclonal antibody, a monoclonal antibody, or a combination thereof. Preferably, the method involves obtaining at least two said samples of body fluid from said patient over a period of time and comparing the BNP levels, with an increase in BNP being indicative of an upcoming rejection episode.
Gowling Lafleur Henderson Llp
Ottawa Heart Institute Research Corporation
LandOfFree
Predicting and detecting cardiac allograft rejection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Predicting and detecting cardiac allograft rejection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Predicting and detecting cardiac allograft rejection will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1852610